Cosopt Versus Xalacom

NCT00273481 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: dorzolamide 2%/timolol maleate 0.5% fixed combination
DRUG: latanoprost 0.005%/timolol maleate 0.5% fixed combination
DRUG: timolol maleate 0.5%
DRUG: placebo

Sponsor

Pharmaceutical Research Network